Strategic COVID-19 Testing Could Prevent Distancing, Shutdowns
Making diagnostic tests for SARS-CoV-2 faster or more available could reduce reliance on costly interventions, such as distancing and shutdowns.
Read MorePosted by Chris Wolski | Nov 1, 2021 | Covid 19, POC Rapid Assays |
Making diagnostic tests for SARS-CoV-2 faster or more available could reduce reliance on costly interventions, such as distancing and shutdowns.
Read MorePosted by Chris Wolski | Oct 29, 2021 | Covid 19, Immunoassay Reagents & test Kits |
BARDA will invest $24.7 million for BD to develop five new COVID-19 combination diagnostic tests for core labs, hospitals, and point-of-care locations.
Read MorePosted by Chris Wolski | Oct 28, 2021 | Covid 19, POC Rapid Assays |
Dotz Nano will introduce its Mega-Diagnostic Platform for en masse, rapid diagnosis of COVID-19 at the point of care.
Read MorePosted by Chris Wolski | Oct 27, 2021 | Covid 19, POC Rapid Assays |
Shipments are now available for the BD Veritor At-Home COVID-19 Test, an over-the-counter COVID-19 rapid antigen test.
Read MorePosted by Chris Wolski | Oct 26, 2021 | POC Instruments |
The wearable VeCare sensor can detect multiple chronic wound biomarkers to facilitate timely, personalized wound management at the point of care.
Read More